| Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp | Diabetes Therapy | 14 hours | save |  |  |  |
| Correction to: A Response to the Letter to the Editor Regarding“Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study” | Diabetes Therapy | 2 days | save | | | |
| Switching from Neutral Protamine Hagedorn (NPH) Insulin to Insulin Glargine 300 U/mL in Older and Younger Patients with Type 2 Diabetes: A Post Hoc Analysis of a Multicenter, Prospective, Observational Study | Diabetes Therapy | 2 days | save | | | |
| Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study | Diabetes Therapy | 3 days | save | | | |
| Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database | Diabetes Therapy | 8 days | save | | | |
| Multinational Observational Study to Understand Insulin Treatment Intensification: Japanese Subgroup Analysis of the MOSAIc Study | Diabetes Therapy | 12 days | save | | | |
| Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER | Diabetes Therapy | 22 days | save | | | |
| Differences in Dental Care Referral for Diabetic Patients Between General Practitioners and Diabetes Specialists in Japan, Analyzed from NSAID-Study 3 | Diabetes Therapy | 23 days | save | | | |
| Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus and Comorbidities? A Multidisciplinary Spanish Qualitative Research | Diabetes Therapy | 30 days | save | | | |
| Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review | Diabetes Therapy | 30 days | save | | | |
| Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study) | Diabetes Therapy | 33 days | save | | | |
| Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results | Diabetes Therapy | 38 days | save | | | |
| Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes | Diabetes Therapy | 38 days | save | | | |
| Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial | Diabetes Therapy | 43 days | save | | | |
| Letter to the Editor Regarding“Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study” | Diabetes Therapy | 47 days | save | | | |
| A Response to the Letter to the Editor Regarding“Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study” to the end of Study | Diabetes Therapy | 47 days | save | | | |
| Prognostic Value of Stress Hyperglycemia in Patients Admitted to Medical/Geriatric Departments for Acute Medical Illness | Diabetes Therapy | 47 days | save | | | |
| Challenges in Insulin Therapy for Type 2 Diabetes | Diabetes Therapy | 69 days | save | | | |
| Improved Glycemic Control Observed in Children with Type 1 Diabetes Following the Introduction of Smart Insulin Pens: A Real-World Study | Diabetes Therapy | 72 days | save | | | |
| Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis | Diabetes Therapy | 78 days | save | | | |
| Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant? | Diabetes Therapy | 97 days | save | | | |
| Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study | Diabetes Therapy | 99 days | save | | | |
| Relationship Between Bedside Ketone Levels and Time to Resolution of Diabetic Ketoacidosis: A Retrospective Cohort Study | Diabetes Therapy | 101 days | save | | | |
| Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study | Diabetes Therapy | 105 days | save | | | |
| The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes | Diabetes Therapy | 106 days | save | | | |
| Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE S | Diabetes Therapy | 108 days | save | | | |
| An Update to the Article“Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis” | Diabetes Therapy | 109 days | save | | | |
| Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM | Diabetes Therapy | 111 days | save | | | |
| Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study | Diabetes Therapy | 113 days | save | | | |
| Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study | Diabetes Therapy | 117 days | save | | | |
| A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities | Diabetes Therapy | 118 days | save | | | |
| Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany | Diabetes Therapy | 121 days | save | | | |
| Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study | Diabetes Therapy | 121 days | save | | | |
| Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study | Diabetes Therapy | 123 days | save | | | |
| Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study | Diabetes Therapy | 124 days | save | | | |
| Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial | Diabetes Therapy | 128 days | save | | | |
| The Therapeutic Effects of Mild to Moderate Intensity Aerobic Exercise on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Trials | Diabetes Therapy | 129 days | save | | | |
| The Association Between Mean Glycated Haemoglobin or Glycaemic Variability and the Development of Retinopathy in People with Diabetes: A Retrospective Observational Cohort Study | Diabetes Therapy | 134 days | save | | | |
| Effects of Different Glucose-Lowering Measures on Maternal and Infant Outcomes in Pregnant Women with Gestational Diabetes: A Network Meta-analysis | Diabetes Therapy | 136 days | save | | | |
| The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and Sitagliptin | Diabetes Therapy | 137 days | save | | | |
| Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy | Diabetes Therapy | 151 days | save | | | |
| Alcohol Consumption as a Causator and/or an Accelerator of Neuropathy in People With Diabetes Is Regularly Overlooked | Diabetes Therapy | 153 days | save | | | |
| Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy | Diabetes Therapy | 154 days | save | | | |
| Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study | Diabetes Therapy | 155 days | save | | | |
| The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond | Diabetes Therapy | 156 days | save | | | |
| Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population | Diabetes Therapy | 156 days | save | | | |
| Effects of Moderate-Intensity Aerobic Exercise on Blood Glucose Levels and Pregnancy Outcomes in Patients With Gestational Diabetes Mellitus: A Randomized Controlled Trial | Diabetes Therapy | 156 days | save | | | |
| The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study | Diabetes Therapy | 160 days | save | | | |
| Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes | Diabetes Therapy | 160 days | save | | | |
| Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study | Diabetes Therapy | 164 days | save | | | |
| | 
report | next » |
| |
